NCT00372151View on ClinicalTrials.gov

L-Theanine in the Management of Schizophrenia

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Schizophrenia
Interventions
DIETARY_SUPPLEMENT

L-Theanine

400 mg/day, caps.

OTHER

Placebo

caps.

Trial Locations (2)

38814

Sha'ar Menashe Mental Health Center, Hadera

Unknown

Be'er Sheva Mental Health Center, Beersheba

All Listed Sponsors
collaborator

Stanley Medical Research Institute

OTHER

collaborator

Beersheva Mental Health Center

OTHER_GOV

lead

Sha'ar Menashe Mental Health Center

OTHER

NCT00372151 - L-Theanine in the Management of Schizophrenia | Biotech Hunter | Biotech Hunter